← Search

Table · dataset · 2026

IgG marks the past, IgA marks the risk: an isotype-stratified meta-analysis of C. pneumoniae and asthma

Listed in figshare

<p>Growing evidence links Chlamydia pneumoniae (C. pneumoniae) infection to asthma pathogenesis, though the consistency and robustness of this association remain disputed.

Description

This study aimed to clarify the associations between different C. pneumoniae antibody isotypes and asthma risk via isotype-stratified meta-analysis, to distinguish past infection markers and predictive risk indicators for asthma.</p> <p>Relevant literature was systematically retrieved from four mainstream databases, including PubMed, Embase, Web of Science, and Cochrane Library, with the retrieval time spanning from database inception to May 2026.

Eligible observational studies focusing on the association between C. pneumoniae seropositivity and asthma were included. Random-effects meta-analysis was adopted for data pooling. Subgroup analysis by age, leave-one-out sensitivity analysis, and Egger’s test for publication bias were performed for comprehensive assessment.</p> <p>A total of 21 qualified studies were enrolled.

Read the rest (2 more)

Cp-IgG seropositivity showed no significant association with asthma (OR = 1.05, 95%CI: 0.90–1.22, I2=0%). Cp-IgA significantly elevated overall asthma risk (OR = 1.43, 95%CI: 1.05–1.96, p = 0.024, I2=56.5%), with a more prominent effect in adults than children. Cp-IgE presented a strong positive association but exhibited poor stability in sensitivity analysis.

No publication bias was observed in Cp-IgG and Cp-IgA analyses.</p> <p>Cp-IgA rather than Cp-IgG is a valid risk marker for asthma, especially in adult populations. Continuous mucosal immune stimulation from persistent C. pneumoniae exposure contributes to asthma development, while Cp-IgE may correlate with specific asthma phenotypes and requires further verification.</p>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 21 field assertions
SourceKeyLast seenRaw
figshareoai:figshare.com:article/3380323812 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · figshare comconnector:figshare_com@1.0.0
concepts[disease].local:disease:cancermapping · figshare comvocabulary-mapper@1.0.0keywords['Cancer']
concepts[field].anzsrc:field:320211mapping · figshare comvocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:field:440710mapping · figshare comvocabulary-mapper@1.0.0keywords['Science Policy']
concepts[field].anzsrc:group:3107mapping · figshare comvocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3204mapping · figshare comvocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].local:field:astronomymapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:chemistrymapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:computer-science-aimapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:economics-financemapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:engineeringmapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:humanitiesmapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:life-sciencesmapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:medicine-healthmapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:ocean-atmosphericmapping · figshare comconnector:figshare_com@1.0.0
concepts[field].local:field:social-sciencemapping · figshare comconnector:figshare_com@1.0.0
descriptionsource · figshare comconnector:figshare_com@1.0.0/metadata/dc/description
licensesource · figshare comconnector:figshare_com@1.0.0/metadata/dc/rights
publication_datesource · figshare comconnector:figshare_com@1.0.0
titlesource · figshare comconnector:figshare_com@1.0.0/metadata/dc/title